Evaluation Process

What is Captisol®?


Captisol is a patent protected, uniquely modified cyclodextrin, whose chemical structure was rationally designed to maximize safety and optimize interaction to improve the solubility, stability and administration of active ingredients.

Ligand offers formulation solutions, in-depth industry knowledge and consulting services to meet your goals. Ligand has strong Captisol®-related alliances with partners to deliver enabling solutions to products.

Licensing

Captisol® is a well-profiled enabling technology available to research and development professionals through flexible licensing arrangements. We work worldwide with companies interested in licensing Captisol® and other SBE-CD technologies to commercialize their products. We also work with our partners to manage life cycles of existing products.

  • Pharmaceutical Product Development services
  • Commercial License and Supply Agreement (LSA)
  • Limited Clinical Use Agreements (LCUAs)

Contact our Licensing Department

Back to Top